References
Kim M, Martin ST, Townsend KR, Gabardi S (2014) Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options. Pharmacotherapy 34(7):733–744
De Joode AA, Sanders JS, Smid WM, Stegeman CA (2014) Plasmapheresis rescue therapy in progressive systemic ANCA-associated vasculitis: single-center results of stepwise escalation of immunosuppression. J Clin Apher. doi:10.1002/jca.21318
Thomas Papo Macrophagic myofasciitis: focal or systemic? Joint Bone Spine 70(4):242–245
Gherardi RK, Authier FJ (2012) Macrophagic myofasciitis: characterization and pathophysiology. Lupus 21(2):184–189
Müller HD, Landeghem FK, Schmidt PF, Sommer C, Goebel HH (2000) Macrophagic myofasciitis plus (distinct types of muscular dystrophy). Neuropediatrics 40:174–178
Cadusseau J, Ragunathan-Thangarajah N, Surenaud M, Hue S, Authier FJ, Gherardi RK (2014) Selective elevation of circulating CCL2/MCP1 levels in PATIENTS with longstanding post-vaccinal macrophagic myofasciitis and ASIA. Curr Med Chem 21(4):511–517
Gherardi RK (2003) Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome. Rev Neurol (Paris). 159(2):162–164
Gherardi RK, Authier FJ (2003) Aluminum inclusion macrophagic myofasciitis: a recently identified condition. Immunol Allergy Clin North Am 23:699–712
Authier FJ, Cherin P, Creange A, Bonnotte B, Ferrer X, Abdelmoumni A, Ranoux D, Pelletier J, Figarella-Branger D, Granel B, Maisonobe T, Coquet M, Degos JD, Gherardi RK (2001) Central nervous system disease in patients with macrophagic myofasciitis. Brain 124(Pt 5):974–983
Guis S, Pellissier JF, Nicoli F et al (2002) HLA-DRB1and macrophagic myofasciitis. Arthritis Rheum 46:2535–2537
Stübgen JP (2014) A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev 13(1):31–39
Shoenfeld Y, Agmon-Levin N (2011) ’ASIA’ Autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4–8
Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y (2013) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 47:1–16
Cruz-Tapias P, Agmon-Levin N, Israeli E, Anaya JM, Shoenfeld Y (2013) Autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA)-animal models as a proof of concept. Curr Med Chem 20(32):4030–4036
Polido Pereira J, Barroso C, Evangelista T, Fonseca JE, Pereira da Silva JA (2011) Macrophagic myofasciitis: a case report of autoimmune/inflammatory syndrome induced by adjuvants (ASIA). Acta Reumatol Port 36(1):75–76
Schwartz J, Winters JL, Padmanabhan A, Balogun RA, Delaney M, Linenberger ML, Szczepiorkowski ZM, Williams ME, Wu Y, Shaz BH (2013) Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue. J Clin Apher 28(3):145–284
Exley C, Swarbrick L, Gherardi RK, Authier FJ (2009) A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome. Med Hypotheses 72(2):135–139
Glynn F, O’Sullivan P (2007) Vocal fold deposits in macrophagic myofasciitis. Ear Nose Throat J 86(4):238–239
Voinov VA (2013) Strategy of efferent therapy in sepsis. Vestn Khir Im I I Grek 172(2):74–77 (Review)
Voĭnov AV, Bedrov AIa, Voinov VA (2012) Syndrome of “diabetic foot”. Vestn Khir Im I I Grek 171(3):106–109 (Review)
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Russo, G.E., De Bono, V., Grynyshyn, D. et al. A young man with persistent myalgia and fatigue: an off-label therapeutic approach. Intern Emerg Med 10, 51–53 (2015). https://doi.org/10.1007/s11739-014-1138-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-014-1138-8